Genetic influence on cytokine production and fatal meningococcal disease

Lancet

Volumn 349, Issue 9046, 1997, Pages 170-173

  Westendorp, Rudi G J ^a   Langermans, Jan A M ^b   Huizinga, Tom W J ^b   Elouali, Abdul H ^b   Verweij, Cornelis L ^b   Boomsma, Dorret I ^b   Vandenbrouke, Jan P ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; ENDOTOXIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CHILD; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FATALITY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HERITABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MONOZYGOTIC TWINS; NUCLEIC ACID BASE SUBSTITUTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031033476     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)06413-6     Document Type: Article

References (19)

1. Sørensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-32.
2. Alexander HR, Sheppard BC, Jensen JC, et al. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J Clin Invest 1991; 88: 34-39.
3. Rothe J, Lesslauer W, Lötscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364: 798-802.
4. Fernandes DM, Baldwin CL. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun 1995; 63: 1130-33.
5. Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J Immunol 1996; 157: 798-805.
6. Westendorp RGJ, Langermans JAM, de Bel CE, et al. Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995; 171: 1057-60.
7. Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996; 153: 1080-66.
8. De Groote D, Zangerie PF, Gevaert Y, et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239-48.
9. Brinkman BMN, Zuydgeest D, Kayzel L, Breedveld FC, Verwey CC. Relevance of the TNF -308 promoter polymorphism in the TNF gene regulation. J Inflammation 1996; 46: 32-41.
10. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF-α gene promoter. Scand J Immunol 1995; 42: 501-04.
11. Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER and dGENE. Genet Epidemiol 1988; 5: 471-72.
12. Lange K, Westlake J, Spence MA. Extensions to pedigree analysis III. Variance components by the scoring method. Ann Hum Genet 1976; 39: 485-91.
13. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-11.
14. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4: 359-95.
15. van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation fibrinolytic, and complement pathways. Blood 1990; 76: 2520-26.
16. Derkx HHF, Bruin KF, Jongeneel CV, van Deventer SJH. Lps reactivity of monocytes and TNF gene polymorphism. In: van Furth R, ed. Mononuclear phagocytes. Gravenhage: Kluwer, 1992: 355-58.
17. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, J5 Study Group, Lambert PH. Tumor necrosis factor and interleukin-I in the serum of children with severe infectious purpura. N Engl J Med 1988; 319: 397-400.
18. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204.
19. Fisher CJ, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996; 334: 1697-702.